ADX-038 not checked

ADARx Pharmaceuticals, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
4 active
4 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
IC-MPGN (2 trials), Immunoglobulin A Nephropathy (IgAN), Complement 3 Glomerulopathy (C3G), Geographic Atrophy Secondary to Age-related Macular Degeneration, IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN) and 1 more
Main trialPhase 2
“This is a Phase 2 study to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics of ADX-038 in adults with complement-mediated kidney diseases. The study will enroll Chinese adults with IgA nephropathy, complement 3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN). The study will evaluate ADX-038 administered alone (Part A) and in combination with telitacicept (Part B).”In the company’s words, NCT07522099 on ClinicalTrials.gov
Other names
siRNA

Other drugs for IC-MPGN

All 9 drugs for IC-MPGN

Coming up4

Changes1

Last 90 days

Trials4

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 10 Jul 2028 Chinese Adults With Kidney Disease
Phase 2Recruiting 28 Feb 2030 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Phase 2Recruiting 30 Apr 2030 Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Phase 1/2Recruiting 31 Mar 2028 Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow ADX-038

Following is part of Solo: you see every change to ADX-038 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in